MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$17,119,438
EPS
-$1.57
Unit: Dollar

Income Statement
2025-12-31
General and administrative
6,464,371
Research and development
11,514,123
Total operating expenses
17,978,494
Loss from operations
-17,978,494
Interest income
437,931
Other income, net
421,125
Net loss
-17,119,438
Basic EPS
-1.57
Diluted EPS
-1.57
Basic Average Shares
10,898,175
Diluted Average Shares
10,898,175
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$17,119,438 Interest income$437,931 Other income, net$421,125 Loss from operations-$17,978,494 Total operatingexpenses$17,978,494 Research and development$11,514,123 General andadministrative$6,464,371

Lantern Pharma Inc. (LTRN)

Lantern Pharma Inc. (LTRN)